Advertisement
News
Subscribe to MDT Magazine News

UTMB named a World Health Organization Collaborating Center for Vaccine Research

August 15, 2014 3:53 pm | by EurekAlert! | Comments

The world experts on vaccine development at the University of Texas Medical Branch at Galveston have received an international designation acknowledging their unique niche in a sphere where research, government regulation and big pharma often collide. UTMB's Sealy Center for Vaccine Development has been named a World Health Organization Collaborating Center for Vaccine Research, Evaluation and Training on Emerging Infectious Diseases.

TOPICS:

3D Printing Cartilage

August 15, 2014 3:44 pm | by EnvisionTEC | Comments

Rocky Tuan, PhD, is a professor and executive vice chairman of the department of orthopedic surgery as well as the director of the Center for Cellular and Molecular Engineering at the University of Pittsburgh School of Medicine developing 3D printed cartilage with the EnvisionTEC Perfactory. This research is the first success of living human cartilage tissue composed atop a chip using 3D printing.

TOPICS:

New ways to treat solid tumors

August 15, 2014 3:24 pm | by Monash University | Comments

An international team of scientists has shown that an antibody against the protein EphA3, found in the micro-environment of solid cancers, has anti-tumor effects. As EphA3 is present in normal organs only during embryonic development but is expressed in blood cancers and in solid tumors, this antibody-based approach may be a suitable candidate treatment for solid tumors.

TOPICS:
Advertisement

New nanotech invention improves effectiveness of the 'penicillin of cancer'

August 15, 2014 3:12 pm | by Jared Sagoff, Argonne National Laboratory | Comments

Scientists at the U.S. Department of Energy's Argonne National Laboratory have added a new weapon to oncologists' arsenal of anti-cancer therapies. By combining magnetic nanoparticles with one of the most common and effective chemotherapy drugs, Argonne researchers have created a way to deliver anti-cancer drugs directly into the nucleus of cancer cells.

TOPICS:

Bats bolster brain hypothesis, maybe technology, too

August 15, 2014 2:49 pm | by EurekAlert! | Comments

Amid a neuroscience debate about how people and animals focus on distinct objects within cluttered scenes, some of the newest and best evidence comes from the way bats "see" with their ears, according to a new paper in the Journal of Experimental Biology. In fact, the perception process in question could improve sonar and radar technology.

TOPICS:

Scientists racing to test Ebola vaccines in humans

August 15, 2014 10:59 am | by Matthew Perrone - Associated Press | Comments

Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines, but it won't be easy to prove that the shots and other potential treatments in the pipeline really work. There are no proven drugs or vaccines for Ebola, a disease so rare that it's been hard to attract investments in countermeasures. But the current outbreak in West Africa—the largest in history—is fueling new efforts to ...

TOPICS:

New gene editing method may help correct muscular dystrophy

August 15, 2014 10:52 am | by University of Texas Southwestern Medical Center | Comments

Univ. of Texas Southwestern Medical Center researchers successfully used a new gene editing method to correct a mutation that leads to Duchenne muscular dystrophy (DMD) in a mouse model of the condition. Researchers used a technique called CRISPR/Cas9-mediated genome editing, which can precisely remove a mutation in DNA, allowing the body's DNA repair mechanisms to ...

TOPICS:

Laser makes microscopes way cooler

August 15, 2014 10:31 am | by EurekAlert! | Comments

Laser physicists have found a way to make atomic-force microscope probes 20 times more sensitive and capable of detecting forces as small as the weight of an individual virus. The technique, developed by researchers at The Australian National University (ANU), hinges on ...

Advertisement

Memories of errors foster faster learning

August 15, 2014 10:18 am | by EurekAlert! | Comments

Using a deceptively simple set of experiments, researchers at Johns Hopkins have learned why people learn an identical or similar task faster the second, third and subsequent time around. The reason: They are aided not only by memories of how to perform the task, but also by memories of the errors made the first time.

TOPICS:

Scientists fold RNA origami from a single strand

August 15, 2014 9:51 am | by EurekAlert! | Comments

RNA origami is a new method for organizing molecules on the nanoscale. Using just a single strand of RNA, many complicated shapes can be fabricated by this technique. Unlike existing methods for folding DNA molecules, RNA origamis are produced by enzymes and they simultaneously fold into pre-designed shapes. These features may allow designer RNA structures to ...

UT Arlington and Pediatrix partner to bring simulation training direct to practice

August 15, 2014 9:45 am | by EurekAlert! | Comments

A real-time video feed, a laptop and a computerized manikin baby are key components for a new simulation training initiative that allows UT Arlington College of Nursing educators to put Neonatal Nurse Practitioners (NNPs) and physicians through the paces of an emergency scenario from hundreds of miles away.

TOPICS:

Coatings for Medical Devices Market Report - Global Forecasts 2020

August 15, 2014 9:32 am | by The Associated Press | Comments

Research and Markets ( http://www.researchandmarkets.com/research/wz6v6m/coatings_for ) has announced the addition of the "Coatings for Medical Devices - Global Strategic Business Report" report to their offering. This report analyzes...

Cook Medical Enrolls First Patient in Zilver PTX Drug Eluting Peripheral Stent Clinical Study in China

August 15, 2014 8:30 am | by The Associated Press | Comments

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Aug 15, 2014--Cook Medical has enrolled the first patient in the clinical study in China of its Zilver® PTX® Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investigators, Prof. Peng Liu, M.D., at the China-Japan Friendship...

CVD Reports 108% Order Increase in Q2

August 14, 2014 7:29 pm | by The Associated Press | Comments

CENTRAL ISLIP, N.Y.--(BUSINESS WIRE)--Aug 14, 2014--CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of custom chemical vapor deposition systems, today announced its financial results for the three and six months ended June 30, 2014. CVD reported new orders of approximately...

Scripps Research Institute chemists uncover powerful new click chemistry reactivity

August 14, 2014 4:23 pm | by EurekAlert! | Comments

Chemists led by Nobel laureate K. Barry Sharpless at The Scripps Research Institute (TSRI) have used his click chemistry to uncover unprecedented, powerful reactivity for making new drugs, diagnostics, plastics, smart materials and many other products. The new SuFEx—Sulfur Fluoride Exchange—reactions enable ...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading